Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

The survival of patients with advanced osteosarcoma is poor with limited therapeutic options. There is an urgent need for new targeted therapies based on biomarkers. Recently, theranostic molecular profiling services for cancer patients by CLIA-certified commercial companies as well as in-house prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Egas-Bejar, Daniela, Anderson, Pete M., Agarwal, Rishi, Corrales-Medina, Fernando, Devarajan, Eswaran, Huh, Winston W., Brown, Robert E, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128257/
https://www.ncbi.nlm.nih.gov/pubmed/25126591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128257/
https://www.ncbi.nlm.nih.gov/pubmed/25126591

Ejemplares similares